Professor Andrew Wei

Professor Andrew Wei


Metcalf Family Cancer Research Fellow and Laboratory Head
Walter and Eliza Hall Institute of Medical Research
Elected in 2023
Citation on election

Professor Andrew Wei is an internationally recognised leader in the field of acute myeloid leukaemia (AML). He has led nationwide trial development in Australia for 14 years as the AML chair for the ALLG. His laboratory has made pre-clinical contributions to the clinical development of BH3-mimetics in AML culminating in the regulatory approval of venetoclax by the FDA in 2020 and the Australian PBAC in 2021. Wei’s lab has conducted research studies investigating the molecular mechanisms of response and resistance to venetoclax-based therapy. He leads the AML program at the Peter MacCallum Cancer Centre and a research laboratory at WEHI.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.